Bulletin
Investor Alert

Eisai Co. Ltd. ADR

OTC: ESALY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202565502/composite

$

90.27

Change

+0.22 +0.24%

Volume

Volume 472

Sep 25, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202565502/composite

Previous close

$ 90.00

$ 90.05

Change

+0.05 +0.06%

Day low

Day high

$90.05

$90.50

Open
Open: 90.50

52 week low

52 week high

$49.06

$92.15

Open

Market cap

$25.84B

Average volume

1,893

P/E ratio

22.50

Rev. per Employee

$543,512

EPS

4.00

Dividend

0.74

Div yield

1.39%

Ex dividend date

3/27/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/esaly

MarketWatch News on ESALY

  1. Biogen says it will pursue FDA approval of early Alzheimer's drug

    6:39 a.m. Oct. 22, 2019

    - Steve Goldstein

  2. Merck Wins Approval for Cancer Treatment in 3 Countries at Once

    11:23 a.m. Sept. 18, 2019

    - Barron's Online

  3. Biogen, Eisai to discontinue phase 3 trial of oral BACE Alzheimer's treatment

    8:05 a.m. Sept. 13, 2019

    - Tomi Kilgore

  4. Health-care earnings: ‘Medicare for all’ looms large

    10:11 a.m. April 23, 2019

    - Sarah Toy

  5. Biogen shares down 9% after Alzheimer's trial results

    5:12 p.m. July 25, 2018

    - Claudia Assis

  6. Biogen’s Bump Good for Biotech

    11:06 a.m. July 9, 2018

    - Barron's Online

  7. Dow Shrugs Off Trade War, Gains on Payroll Surprise

    11:07 a.m. July 9, 2018

    - Barron's Online

  8. Amgen to help develop Novartis's Alzheimer's drugs

    4:32 p.m. Sept. 1, 2015

    - MarketWatch.com

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/esaly

Other News on ESALY

  1. Gilead's Jyseleca Ok'd in Japan for rheumatoid arthritis

    6:27 a.m. Sept. 25, 2020

    - Seeking Alpha

  2. Keytruda/Lenvima combo shows positive action in range of cancers

    9:15 a.m. Sept. 21, 2020

    - Seeking Alpha

  3. Biogen Stock Is a Big Risk Worth Taking

    2:07 p.m. Sept. 1, 2020

    - The Wall Street Journal Interactive Edition

  4. Avenue Therapeutics (ATXI) Misses Earnings Estimates in Q2

    10:33 a.m. Aug. 17, 2020

    - Zacks.com

  5. Biogen Taps Iqvia CFO as New Finance Chief

    8:35 p.m. July 21, 2020

    - The Wall Street Journal Interactive Edition

  6. New Strong Sell Stocks for July 6th

    8:18 a.m. July 6, 2020

    - Zacks.com

  7. Keytruda/Lenvima combo shows benefit liver and kidney cancers

    7:26 a.m. May 29, 2020

    - Seeking Alpha

  8. Eisai Co., Ltd. 2019 Q4 - Results - Earnings Call Presentation

    10:12 a.m. May 13, 2020

    - Seeking Alpha

  9. 10-Q: ARENA PHARMACEUTICALS INC

    5:36 p.m. May 7, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  10. 10-Q: EPIZYME, INC.

    7:01 a.m. May 4, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  11. Axsome Shares Jump 25% on Alzheimer's Study Results

    9:16 a.m. April 28, 2020

    - GuruFocus.com

  12. Lantern Pharma on deck for IPO

    3:50 p.m. April 16, 2020

    - Seeking Alpha

  13. Insulin Giant Aims to Unlock Elusive Obesity-Drug Market

    8:18 p.m. March 3, 2020

    - The Wall Street Journal Interactive Edition

  14. Loading more headlines...
/news/pressrelease/company/us/esaly

Press Releases on ESALY

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.